Tag : Pending

Latest News

Gilead and Eisai Enter Into Agreement in Japan for the Co-Promotion of the Investigational Rheumatoid Arthritis Therapy Filgotinib, Pending Regulatory Approval

Newsemia
FOSTER CITY, Calif. & TOKYO–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) and Eisai Co., Ltd. (Tokyo, Japan) announced today that Gilead Sciences K.K. (Tokyo, Japan) and...
Neurology

PRAC Restricts Use of Alemtuzumab for MS Pending Ongoing Review

Newsemia
The EMA committee recommends updating the product information to note the potential for acute immune-mediated conditions, stroke, cervicocephalic arterial dissection, and severe neutropenia. News Alerts...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy